First Header Logo Second Header Logo

Connection

Ashok Hemal to Prognosis

This is a "connection" page, showing publications Ashok Hemal has written about Prognosis.
Connection Strength

0.463
  1. Aboumohamed AA, Krane LS, Hemal AK. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma. J Urol. 2015 Dec; 194(6):1561-6.
    View in: PubMed
    Score: 0.094
  2. Krane LS, Richards KA, Kader AK, Davis R, Balaji KC, Hemal AK. Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy. J Endourol. 2013 Aug; 27(8):1046-50.
    View in: PubMed
    Score: 0.082
  3. Manny TB, Krane LS, Hemal AK. Indocyanine green cannot predict malignancy in partial nephrectomy: histopathologic correlation with fluorescence pattern in 100 patients. J Endourol. 2013 Jul; 27(7):918-21.
    View in: PubMed
    Score: 0.081
  4. Mumtaz FH, Kommu SS, Siddiqui E, Le Roux PJ, Hellawell G, Hemal AK. Minimally invasive treatment of ureteropelvic junction obstruction: optimizing outcomes with concomitant cost reduction. J Endourol. 2006 Sep; 20(9):663-8.
    View in: PubMed
    Score: 0.051
  5. Hemal AK, Khaitan A, Dinda AK, Gupta NP, Seth A, Dogra PN, Nabi G. Prognostic significance of p53 nuclear overexpression in patients of muscle invasive urinary bladder carcinoma treated with cystectomy. Urol Int. 2003; 70(1):42-6.
    View in: PubMed
    Score: 0.039
  6. Beksac AT, Paulucci DJ, Gul Z, Reddy BN, Kannappan M, Martini A, Sfakianos JP, Gin GE, Abaza R, Eun DD, Bhandari A, Hemal AK, Porter J, Badani KK. Risk factors and prognostic implications for pathologic upstaging to T3a after partial nephrectomy. Minerva Urol Nefrol. 2019 Aug; 71(4):395-405.
    View in: PubMed
    Score: 0.029
  7. Winoker JS, Paulucci DJ, Anastos H, Waingankar N, Abaza R, Eun DD, Bhandari A, Hemal AK, Sfakianos JP, Badani KK. Predicting Complications Following Robot-Assisted Partial Nephrectomy with the ACS NSQIP® Universal Surgical Risk Calculator. J Urol. 2017 10; 198(4):803-809.
    View in: PubMed
    Score: 0.027
  8. Marshall SJ, Hayn MH, Stegemann AP, Agarwal PK, Badani KK, Balbay MD, Dasgupta P, Hemal AK, Hollenbeck BK, Kibel AS, Menon M, Mottrie A, Nepple K, Pattaras JG, Peabody JO, Poulakis V, Pruthi RS, Palou Redorta J, Rha KH, Richstone L, Schanne F, Scherr DS, Siemer S, Stöckle M, Wallen EM, Weizer AZ, Wiklund P, Wilson T, Woods M, Guru KA. Impact of surgeon and volume on extended lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium (IRCC). BJU Int. 2013 Jun; 111(7):1075-80.
    View in: PubMed
    Score: 0.020
  9. Kolla SB, Seth A, Singh MK, Gupta NP, Hemal AK, Dogra PN, Kumar R. Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy. Int Urol Nephrol. 2008; 40(2):321-7.
    View in: PubMed
    Score: 0.014
  10. Gupta NP, Kolla SB, Seth A, Hemal AK, Dogra PN, Kumar R. Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy. J Urol. 2007 Oct; 178(4 Pt 1):1206-11; discussion 1211.
    View in: PubMed
    Score: 0.014
  11. Sivaramakrishna B, Gupta NP, Wadhwa P, Hemal AK, Dogra PN, Seth A, Aron M, Kumar R. Pattern of metastases in renal cell carcinoma: a single institution study. Indian J Cancer. 2005 Oct-Dec; 42(4):173-7.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.